Pharmafile Logo

Debra Ainge

- PMLiVE

A look ahead to key trial readouts at ESMO

New combinations and novel mechanisms on show

The future of medicine has to be data-driven

How combining AI and expert knowledge is supporting clinicians in the age-old battle against cancer

- PMLiVE

Leave or remain? Winning the employee referendum

Six simple things that employers can do to keep their best workers

- PMLiVE

Brexit migration measures threaten UK clinical research

Calls for less restrictive working visa requirements

- PMLiVE

RET rivals Loxo and Blueprint face off with early-stage data

No clear winner between RET inhibitor rivals

- PMLiVE

Orchard plans IPO as gene therapy pipeline advances

UK biotech seeks funds for expanded rare disease portfolio

- PMLiVE

The power of video

Video is not a new marketing channel. Compared to the realms of augmented and virtual reality it’s been around for donkey’s years. And yet video has continued to grow in...

Page & Page Health

- PMLiVE

Lucid’s Big Fat Charity Pub Quiz

Last week Lucid SPIRIT held the first ever Lucid Big Fat Charity Pub Quiz to raise money for our charity partner, Wycombe Homeless Connection (WHC).There were fabulous prizes to be...

Lucid Group Communications Limited

- PMLiVE

China: AstraZeneca’s new engine for growth and innovation

AstraZeneca’s Mark Mallon talks to PME about how its long-term investment in China is paying off

Medtech’s mixed-up monsters

Conglomerate medtechs only make sense in the light of evolution

- PMLiVE

KAM 2.0

Elevating Key Account Management beyond country limits

- PMLiVE

Chinese biotech’s global ambitions

BeiGene aims to be the first home-grown big biopharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links